Nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (CHL) after autologous transplantation: 5‐year overall survival from the phase 2 CheckMate 205 study Meeting Abstract
| Authors: | Ansell, S. M.; Bröckelmann, P. J.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G. P.; Cohen, J. B.; De Boer, J. P.; Kuruvilla, J.; Savage, K. J.; Trneny, M.; Provencio, M.; Jaeger, U.; Willenbacher, W.; Swanink, R.; Sacchi, M.; Shipp, M. A.; Engert, A.; Armand, P. |
| Abstract Title: | Nivolumab for relapsed or refractory (R/R) classical Hodgkin lymphoma (CHL) after autologous transplantation: 5‐year overall survival from the phase 2 CheckMate 205 study |
| Meeting Title: | 16th International Conference on Malignant Lymphoma - Virtual Edition |
| Journal Title: | Hematological Oncology |
| Volume: | 39 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Jun 18-22 |
| Meeting Location: | Virtual |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2021-06-01 |
| Start Page: | 122 |
| End Page: | 125 |
| Language: | English |
| ACCESSION: | 150947639 |
| DOI: | 10.1002/hon.74_2879 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 34105791 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 074 -- Accession Number: 150947639 -- Entry Date: In Process -- Revision Date: 20210618 -- Publication Type: Article -- Supplement Title: Jun2021 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: Cinahl |
